Literature DB >> 23952870

Efficacy of sirolimus therapy for chylous effusions in lymphangioleiomyomatosis.

Pilar Barrera, Sami O Simons, Bart Luijk, Marion J C Wessels, Yvonne F Heijdra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23952870     DOI： 10.1513/AnnalsATS.201212-125OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  7 in total

1.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

2.  Management of refractory chylothorax in pulmonary lymphangioleiomyomatosis.

Authors:  Claire M Ellender; Trevor J Williams; Julian Gooi; Gregory I Snell; Helen M Whitford
Journal:  Respirol Case Rep       Date:  2015-05-18

Review 3.  Recent advances in the management of lymphangioleiomyomatosis.

Authors:  Kai-Feng Xu; Xinlun Tian; Jay H Ryu
Journal:  F1000Res       Date:  2018-06-18

Review 4.  High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.

Authors:  Uchenna Unachukwu; Kiran Chada; Jeanine D'Armiento
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

5.  Renal neoplasms in tuberous sclerosis mice are neurocristopathies.

Authors:  Uchenna Unachukwu; Takayuki Shiomi; Monica Goldklang; Kiran Chada; Jeanine D'Armiento
Journal:  iScience       Date:  2021-06-04

6.  Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.

Authors:  Yongzhong Zhan; Lisha Shen; Wenshuai Xu; Xiuxiu Wu; Weihong Zhang; Jun Wang; Xue Li; Yanli Yang; Xinlun Tian; Kai-Feng Xu
Journal:  Orphanet J Rare Dis       Date:  2018-02-20       Impact factor: 4.123

7.  Additional Octreotide Therapy to Sirolimus Achieved a Decrease in Sirolimus-refractory Chylous Effusion Complicated with Lymphangioleiomyomatosis.

Authors:  Masashi Namba; Takeshi Masuda; Takashi Nakamura; Yasushi Horimasu; Shintaro Miyamoto; Taku Nakashima; Hiroshi Iwamoto; Kazunori Fujitaka; Hironobu Hamada; Noboru Hattori
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.